Histologic Remission

Histologic Remission is a pharmacotherapeutic outcome construct in inflammatory bowel disease that denotes the absence of microscopic inflammation in colonic mucosal tissue, distinguished from clinical or endoscopic remission by its reliance on histopathological evaluation to confirm mucosal healing at the cellular level.

1.8K

Publications

115K

Citations

10.7K

Authors

2.3K

Institutions

Publications per year

2017–2026

448

Authors

10.7K

  1. WJ
    William J. Sandborn

    University of California San Diego, United States

    45 publications · 9.7K citations

    33

    h-index

  2. GD
    Geert D’Haens

    Amsterdam UMC Location University of Amsterdam, Netherlands

    39 publications · 6.4K citations

    27

    h-index

  3. SD
    Silvio Danese

    Humanitas University, Italy

    39 publications · 4.2K citations

    27

    h-index

  4. LP
    Laurent Peyrin‐Biroulet

    Inserm, France

    34 publications · 3.3K citations

    26

    h-index

  5. SV
    Séverine Vermeire

    KU Leuven, Belgium

    40 publications · 4.1K citations

    26

    h-index

1–5 of 10.7K

Venues

  1. Cancer

    90 publications · 6.5K citations

    43

    h-index

  2. Alimentary Pharmacology & Therapeutics

    65 publications · 4.9K citations

    42

    h-index

  3. Inflammatory Bowel Diseases

    73 publications · 4.6K citations

    41

    h-index

  4. Gastroenterology

    58 publications · 13.3K citations

    40

    h-index

  5. PubMed

    Repository · 149 publications · 5.3K citations

    37

    h-index

1–5